Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 10, 1996, Pages 2243-2247

  Hata, Katsura ^a   Kimura, Junko ^a   Miki, Hikari ^a   Toyosawa, Toshio ^a   Moriyama, Megumi ^a   Katsu, Kanemasa ^a  

^a EISAI CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; RAVUCONAZOLE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CANDIDIASIS; COLONY FORMING UNIT; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DRUG EFFICACY; DRUG STRUCTURE; FEMALE; LUNG ASPERGILLOSIS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TISSUE HOMOGENATE;

EID: 0029816731     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.10.2243     Document Type: Article

References (31)

1. Allendoerfer, R., D. Loebenberg, M. G. Rinaldi, and J. R. Graybill. 1995. Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis. Antimicrob. Agents Chemother. 39:1345-1348.
2. Barchiesi, F., A. L. Colombo, D. A. Mcgough, A. W. Fothergill, and M. G. Rinaldi. 1994. In vitro activity of itraconazole against fluconazole-susceptible and resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 38: 1530-1533.
3. Bossche, H. V., P. Marichal, F. C. Odds, L. Le Jeune, and M.-C. Coene. 1992. Characterization of azole-resistant Candida glabrata isolate. Antimicrob. Agents Chemother. 36:2602-2610.
4. DeGregorio, M. W., W. M. F. Lee, C. A. Linker, R. A. Jacobs, and C. A. Ries. 1982. Fungal infections in patients with acute leukemia. Am. J. Med. 73: 543-548.
5. Denning, D. W., J. Y. Lee, J. S. Hostetler, P. Pappas, C. A. Kauffman, D. H. Dewsnup, J. N. Galgiani, J. R. Graybill, A. M. Sugar, A. Catanzaro, H. Gallis, J. R. Perfect, B. Dockery, W. E. Dismukes, and D. A. Stevens. 1994. NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am. J. Med. 97:135-144.
6. Denning, D. W., R. M. Tucker, L. H. Hanson, and D. A. Stevens. 1989. Treatment of invasive aspergillosis with itraconazole. Am. J. Med. 86:791-800.
7. Espinel-Ingroff, A., S. Shadomy, and R. J. Gebhart. 1984. In vitro studies with R51,211 (itraconazole). Antimicrob. Agents Chemother. 26:5-9.
8. Georgopapadakou, N. H., and T. J. Walsh. 1996. Antifungal agents: chemotherapeutic targets and immunologie strategies. Antimicrob. Agents Chemother. 40:279-291.
9. Graybill, J. R. 1989. New antifungal agents. Eur. J. Clin. Microbiol. Infect. Dis. 5:402-412.
10. Hata, K., J. Kimura, H. Miki, T. Toyosawa, T. Nakamura, and K. Katsu. 1996. In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum. Antimicrob. Agents Chemother. 40:2237-2242.
11. Hay, R. J. 1991. Antifungal therapy and new azole compound. J. Antimicrob. Chemother. 28(Suppl. A):35-46.
12. He, X., R. N. Tiballi, L. T. Zarins, S. F. Bradley, J. A. Sangeorzan, and C. A. Kauffman. 1994. Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 38:2495-2497.
13. Hector, R. F., and E. Yee. 1990. Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis. Antimicrob. Agents Chemother. 34:448-454.
14. Hitchcock, C. A., G. W. Pye, P. F. Troke, E. M. Johnson, and D. W. Warnock. 1993. Fluconazole resistance in Candida glabrata. Antimicrob. Agents Chemother. 37:1962-1965.
15. Hoag, K. A., N. E. Street, G. B. Huffnagle, and M. F. Lipscomb. 1995. Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. Am. J. Respir. Cell. Mol. Biol. 13:487-495.
16. + T cells during a pulmonary Cryptococcus neoformans infection. J. Immunol. 155:4790-4797.
17. Jones, J. H., and C. Russell. 1974. The histology of chronic candidal infection of rat's tongue. J. Pathol. 113:97-100.
18. Larsen, R. A. 1990. AIDS commentary: azoles and AIDS. J. Infect. Dis. 162:727-730.
19. Meyer, R. D., L. S. Young, D. Armstrong, and B. Yu. 1973. Aspergillosis complicating neoplastic disease. Am. J. Med. 54:6-15.
20. Myerowitz, R. L., G. J. Pazin, and C. M. Allen. 1977. Disseminated candidiasis: changes in incidence, underlying disease, and pathology. Am. J. Clin. Pathol. 68:29-38.
21. National Committee for Clinical Laboratory Standards. 1992. Reference method for broth dilution antifungal susceptibility testing for yeasts. Proposed standard M27-P. National Committee for Clinical Laboratory Standards, Villanova, Pa.
22. Pietroski, N. A., D. Pharm, and J. Stern. 1990. Cryptococcal meningitis and other fungal infections of the central nervous system. Curr. Opin. Infect. Dis. 3:608-613.
23. Richardson, K., K. W. Brammer, M. S. Marriott, and P. F. Troke. 1985. Activity of UK-49,858, a bistriazole derivative, against experimental infection with Candida albicans and Trichophyton mentagrophytes. Antimicrob. Agents Chemother. 27:832-835.
24. Sawyer, R. 1990. Experimental pulmonary candidiasis. Mycopathologia 109: 99-109.
25. Sawyer, R. T., and A. G. Harmsen. 1989. The relative contribution of resident pulmonary alveolar macrophage and inflammatory polymorphonuclear neutrophils in host resistance to pulmonary infection by Candida albicans. Mycopathologia 108:95-105.
26. Toyosawa, T., K. Hata, J. Ueno, M. Moriyama, and K. Katsu. 1994. Effects of cefclidin on experimental respiratory infection caused by Pseudomonas aeruginosa in immunosuppressed mice. Chemotherapy (Tokyo) 42:1242-1246.
27. Uchida, K., and H. Yamaguchi. 1991. The therapeutic effects of itraconazole, a new triazole antifungal agent, for experimental fungal infections. Jpn. J. Antibiot. 44:588-599.
28. Van Cutsem, J., F. Van Gerven, M.-A. Van de Van, M. Borgers, and P. A. J. Janssen. 1984. Itraconazole, a new triazole that is orally active in aspergillosis. Antimicrob. Agents Chemother. 26:527-534.
29. Van Zant, G. 1984. Studies of hematopoietic stem cells spared by 5-fluorouracil. J. Exp. Med. 159:679-690.
30. Venkateswarlu, K., D. W. Denning, N. J. Manning, and S. L. Kelly. 1995. Resistance of fluconazole in Candida albicans from AIDS patients correlated with reduced intracellular accumulation of drug. FEMS Microbiol. Lett. 131:337-341.
31. Yamaguchi, H., K. Makimura, H. Kume, and M. Okudaira. 1993. Recent trend of deep-seated mycoses in Japan and related medical problems. Prog. Med. 13:2675-2681.